Compare Mesoblast Limited (MESO) vs abrdn Physical Palladium Shares ETF (PALL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs abrdn Physical Palladium Shares ETF — how do they compare? Mesoblast Limited trades at $16.98 (market cap $2.21B), while abrdn Physical Palladium Shares ETF trades at $25.08. The key difference: Mesoblast Limited is trading nearer its 52-week high, abrdn Physical Palladium Shares ETF nearer its low. Which is the better fit depends on your goals.
| MESO | PALL | |
|---|---|---|
Market Cap | $2.21B | — |
Sector | Technology | Commodities - Metals/Agriculture |
52-Week High | $20.96 | $37.18 |
52-Week Low | $12.88 | $19.96 |
Enterprise Value | $2.21B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About abrdn Physical Palladium Shares ETF
PALL is a physically-backed ETF that tracks the spot price of palladium. It holds physical bullion in secure vaults, offering a liquid way to invest in this precious metal primarily used in automotive catalytic converters and electronics.
Read more on PALL →
